WallStSmart

Churchill Capital Corp XI (CCXI)vsJATT Acquisition Corp (JATT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

JATT leads profitability with a 0.0% profit margin vs 0.0%. JATT earns a higher WallStSmart Score of 28/100 (F).

CCXI

Avoid

24

out of 100

Grade: F

Growth: 4.3Profit: 4.0Value: 5.0Quality: 6.0
Piotroski: 2/9

JATT

Avoid

28

out of 100

Grade: F

Growth: 3.7Profit: 5.0Value: 5.0Quality: 6.0
Piotroski: 2/9

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCXI0 strengths · Avg: 0/10

No standout strengths identified

JATT1 strengths · Avg: 9.0/10
Return on EquityProfitability
20.8%9/10

Every $100 of equity generates 21 in profit

Areas to Watch

CCXI4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$677.31M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
4.7%3/10

ROE of 4.7% — below average capital efficiency

JATT4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

Market CapQuality
$41.93M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Operating MarginProfitability
0.0%3/10

Operating margin of 0.0%

Comparative Analysis Report

WallStSmart Research

Bull Case : CCXI

CCXI has a balanced fundamental profile.

Bull Case : JATT

The strongest argument for JATT centers on Return on Equity.

Bear Case : CCXI

The primary concerns for CCXI are Revenue Growth, EPS Growth, Market Cap.

Bear Case : JATT

The primary concerns for JATT are Revenue Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

JATT is growing revenue faster at 0.0% — sustainability is the question.

CCXI generates stronger free cash flow (-326,107), providing more financial flexibility.

Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

JATT scores higher overall (28/100 vs 24/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Churchill Capital Corp XI

FINANCIAL SERVICES · SHELL COMPANIES · USA

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.

JATT Acquisition Corp

FINANCIAL SERVICES · SHELL COMPANIES · USA

JATT Acquisition Corp is a special purpose acquisition company (SPAC) targeting opportunities within the technology and media sectors. With a focus on facilitating mergers, asset acquisitions, and business combinations, JATT leverages the deep industry expertise of its management team to identify transformative transactions that enhance shareholder value. By partnering with innovative firms ready for expansion, JATT is committed to providing strategic resources and capital access, positioning itself as a catalyst for growth and long-term success in the rapidly evolving market landscape.

Want to dig deeper into these stocks?